AsoGen Therapeutics IVS — Credit Rating and Financial Key Figures

AsoGen Therapeutics IVS (CVR number: 40357092) is a company from ODENSE. The company recorded a gross profit of -7 kDKK in 2020. The operating profit was -18.1 kDKK, while net earnings were -39.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -6.3 %, which can be considered poor and Return on Equity (ROE) was -15.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -19 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. AsoGen Therapeutics IVS's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.